LONDON,ENGLAND - MAY 30: A photo illustration of a Mounjaro pen on May 30 2025 in London, England. ... More Mounjaro is a treatment for weight loss and type 2 diabetes. (Photo by Peter Dazeley via Ge… [+3749 chars]...
Read moreCheng Xin / Getty Images Enphase Energy was among the solar stocks that plunged after the Senate approved the full removal of clean-energy tax credits.
Cambridge, MA - July 11: Verve CEO and cofounder Sekar Kathiresan. Cambridge company Verve ... More Therapeutics announced on Tuesday morning that it has dosed the first patient with its new CRISPR g… [+2991 chars]...
Read moreThe most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly.
Novo Nordisk (NVO) makes Ozempic, the best-known GLP-1 drug out today. And until quite recently, the Danish pharma giant consistently led the pack in new prescriptions, becoming virtually synonymous … [+6478 chars]...
Read moreNovo Nordisk (NVO, Financials) is seeing more U.S. teens start treatment with its GLP-1 drug Wegovy; new data shows a 50% increase in prescriptions in 2024. According to health tech firm Truveta, the… [+1447 chars]...
Read more